Will pituitary adenomas regrow after gross total resection? This ranks among the most frequent questions raised by postoperative patients.

Pathologically, pituitary adenomas are benign neoplasms, which theoretically eliminates the risk of recurrence following complete removal. However, the concept of "complete resection" has inherent limitations in surgical practice: instruments can only resect macroscopically visible tissue, while residual tumor cells at the microscopic cellular level cannot be fully eliminated. Even when surgeons utilize operating microscopes or endoscopes to their maximum capacity, they can only confirm "no visible residual lesion", rather than "zero remaining tumor cells".

A simple analogy: a rice vat may appear empty, yet one or two grains may lodge in tiny crevices at the bottom. Invisibility does not mean absence. These residual cells may remain dormant for years, or proliferate and become detectable during a follow-up scan. Clinically, numerous cases present tumor recurrence seven, eight or even more years after pituitary adenoma surgery.

For this reason, regular surveillance cannot be skipped, regardless of whether the operative note states "gross total resection" or "subtotal resection". Every follow-up MRI must be compared with prior imaging to identify morphological changes and growth velocity — these findings determine whether secondary intervention is necessary. Relying solely on subjective physical symptoms to judge recurrence often results in delayed treatment.

Two patient subgroups warrant heightened postoperative vigilance: those with preoperative imaging evidence of tumor invasion into adjacent structures such as the cavernous sinus, and patients whose postoperative pathological report indicates low tumor differentiation. Both groups carry an elevated recurrence risk. The frequency of follow-up visits should be determined through consultation with the attending surgeon, and patients must not arbitrarily extend surveillance intervals.